Safety of Alopecia Treatments in Patients With Breast Cancer and High-Risk Women: A Review

    July 2025 in “ American Journal of Clinical Dermatology ”
    Caitlin A. Kearney, Anna Brinks, Carli D. Needle … Kristen I. Lo Sicco
    Studysummary Alopecia treatments like 5α-reductase inhibitors and spironolactone are safe for breast cancer patients and high-risk women.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on link.springer.com →
    Discuss this study in the Community →

    Research cited in this study 73

    1. Frontal Fibrosing Alopecia Part II: Etiopathogenesis and Management Journal of the American Academy of Dermatology · 2025
    2. Alopecia Areata and Malignancies: Uncertainties Clarified by a Large-Scale Population-Based Study Archives of Dermatological Research · 2024
    3. Analysis of Breast Health Outcomes in Women on Oral 5-Alpha Reductase Inhibitors: A Single-Center Retrospective Cohort Study Journal of the American Academy of Dermatology · 2024
    4. Drugs and Androgenetic Alopecia: What to Look Out For 2024
    5. Low-Dose Metformin and Profibrotic Signature in Central Centrifugal Cicatricial Alopecia JAMA Dermatology · 2024
    6. Oral Minoxidil for Late Alopecia in Cancer Survivors Breast Cancer Research and Treatment · 2024
    7. Efficacy and Safety of Deuruxolitinib, an Oral Selective Janus Kinase Inhibitor, in Adults with Alopecia Areata: Results from the Phase 3 Randomized, Controlled Trial (THRIVE-AA1) Journal of the American Academy of Dermatology · 2024
    8. Treatment of Central Centrifugal Cicatricial Alopecia with Topical Metformin 10% Cream: Case Report and Literature Review International Journal of Dermatology · 2024
    9. Enhanced Insights Into Frontal Fibrosing Alopecia: Advancements in Pathogenesis Understanding and Management Strategies Dermatology and Therapy · 2024
    10. Safety of Antiandrogens for the Treatment of Female Androgenetic Alopecia with Respect to Gynecologic Malignancies Journal of clinical medicine · 2024
    11. Use of Diphenylcyclopropenone for Alopecia Areata Treatment During Pregnancy JAAD Case Reports · 2024
    12. Spironolactone Treatment for Dermatologic Indications Is Not Associated With Hypotension in a Single-Center Retrospective Study Journal of the American Academy of Dermatology · 2024
    13. Safety and Efficacy of Minoxidil Treatment in Scarring Alopecia: A Scoping Review PubMed · 2024
    14. European Expert Consensus Statement on the Systemic Treatment of Alopecia Areata JEADV. Journal of the European Academy of Dermatology and Venereology/Journal of the European Academy of Dermatology and Venereology · 2024
    15. Oral and Topical Administration of Standardized Saw Palmetto Oil Reduces Hair Fall and Improves Hair Growth in Androgenetic Alopecia Subjects: A 16-Week Randomized, Placebo-Controlled Study Clinical, Cosmetic and Investigational Dermatology · 2023
    16. Alopecia Areata: Current Treatments and New Directions American Journal of Clinical Dermatology · 2023
    17. Use of 5-Alpha Reductase Inhibitors in Dermatology: A Narrative Review Dermatology and Therapy · 2023
    18. Androgenetic Alopecia: Therapy Update Drugs · 2023
    19. Exploring The Historical Stigma Of Spironolactone Use In Breast Cancer Survivors With Alopecia International Journal of Women's Dermatology · 2023
    20. Efficacy and Safety of Ritlecitinib in Adults and Adolescents With Alopecia Areata: A Randomised, Double-Blind, Multicentre, Phase 2b–3 Trial The Lancet · 2023
    21. Female Pattern Hair Loss: Therapeutic Update Anais Brasileiros De Dermatologia · 2023
    22. Hair Regrowth in Endocrine Therapy Alopecia With Dutasteride Treatment in Women With Estrogen Positive Breast Cancer JAAD case reports · 2023
    23. Oral Low-Dose Naltrexone in the Treatment of Frontal Fibrosing Alopecia and Lichen Planopilaris: An Uncontrolled Open-Label Prospective Study Curēus · 2023
    24. The Efficacy, Safety, and Recurrence Rate of Diphenylcyclopropenone Topical Immunotherapy for Alopecia Areata: A Systematic Review and Meta-Analysis Dermatologic therapy · 2023
    25. Efficacy of Low-Dose Oral Minoxidil in the Management of Anticancer Therapy-Induced Alopecia in Patients With Breast Cancer: A Retrospective Cohort Study Journal of The American Academy of Dermatology · 2022
    26. Reversible Hair Loss in a Patient With Cicatricial Alopecia: A Case of Regrowth Associated With Pioglitazone Use JAAD case reports · 2022
    27. The State-of-the-Art in the Management of Androgenetic Alopecia: A Review of New Therapies and Treatment Algorithms JEADV Clinical Practice · 2022
    28. Anti-Invasive Effects of Minoxidil on Human Breast Cancer Cells: Combination with Ranolazine Clinical & Experimental Metastasis · 2022
    29. Lichen Planopilaris and Frontal Fibrosing Alopecia: Review and Update of Diagnostic and Therapeutic Features Anais brasileiros de dermatologia/Anais Brasileiros de Dermatologia · 2022
    30. Two Phase 3 Trials of Baricitinib for Alopecia Areata The New England Journal of Medicine · 2022
    31. Intralesional Vitamin D3 in Treatment of Alopecia Areata: A Randomized Controlled Clinical Trial Journal of Cosmetic Dermatology · 2022
    32. Association of Spironolactone Use With Risk of Cancer: A Systematic Review and Meta-Analysis JAMA Dermatology · 2022
    33. Treatment of Alopecia Totalis, Universalis, and Focalis with Vitamin D and Analogs: Three Case Reports and a Literature Review World Journal of Clinical Pediatrics · 2021
    34. Treatment Options for Androgenetic Alopecia: Efficacy, Side Effects, Compliance, Financial Considerations, and Ethics Journal of Cosmetic Dermatology · 2021
    35. Clinicopathologic Characteristics and Response to Treatment of Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors JAMA Dermatology · 2021
    36. Role of Vitamin D in Hair Loss: A Short Review Journal of Cosmetic Dermatology · 2021
    37. Use of H-1 Antihistamine in Dermatology: More Than Itch and Urticaria Control: A Systematic Review Dermatology and Therapy · 2021
    38. Hormonal Contraceptives And Dermatology American Journal of Clinical Dermatology · 2020
    39. Efficacy of Antihistamines in Combination with Topical Corticosteroid and Superficial Cryotherapy for Treatment of Alopecia Areata: A Retrospective Cohort Study Journal of the American Academy of Dermatology · 2020
    40. Spironolactone Use Does Not Increase the Risk of Female Breast Cancer Recurrence: A Retrospective Analysis Journal of The American Academy of Dermatology · 2020
    41. Clascoterone as a Novel Treatment for Androgenetic Alopecia Clinical and Experimental Dermatology · 2020
    42. Repurposing Kir6/SUR2 Channel Activator Minoxidil to Arrest Growth of Gynecologic Cancers Frontiers in pharmacology · 2020
    43. Efficacy and Safety of Topical Calcipotriol 0.005% Versus Topical Clobetasol 0.05% in the Management of Alopecia Areata: An Intrasubject Pilot Study Dermatology and therapy · 2020
    44. Spironolactone for Treatment of Female Pattern Hair Loss Journal of The American Academy of Dermatology · 2020
    45. Hair Regrowth in Two Patients with Recalcitrant Central Centrifugal Cicatricial Alopecia After Use of Topical Metformin JAAD Case Reports · 2020
    46. Topical Antiandrogen Therapies for Androgenetic Alopecia and Acne Vulgaris American Journal of Clinical Dermatology · 2019
    47. Female Androgenetic Alopecia: An Update on Diagnosis and Management American Journal of Clinical Dermatology · 2019
    48. Cyclosporine for Moderate-to-Severe Alopecia Areata: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial of Efficacy and Safety Journal of the American Academy of Dermatology · 2019
    49. Medical Therapy for Frontal Fibrosing Alopecia: A Review and Clinical Approach Journal of The American Academy of Dermatology · 2019
    50. Frontal Fibrosing Alopecia: Efficacy of Treatment Modalities International Journal of Women's Health · 2019
    51. Case Report of Novel Combination of Anthralin and Calcipotriene Leading to Trichologic Response in Alopecia Areata JAAD case reports · 2019
    52. Cortexolone 17α-Propionate (Clascoterone) Is an Androgen Receptor Antagonist in Dermal Papilla Cells In Vitro PubMed · 2019
    53. Vitamin D and Alopecia Areata: Possible Roles in Pathogenesis and Potential Implications for Therapy PubMed · 2019
    54. Safety of 5α-Reductase Inhibitors and Spironolactone in Breast Cancer Patients Receiving Endocrine Therapies Breast Cancer Research and Treatment · 2018
    55. Treatment of Alopecia Areata: An Australian Expert Consensus Statement Australasian journal of dermatology · 2018
    56. Endocrine Therapy-Induced Alopecia in Patients With Breast Cancer JAMA Dermatology · 2018
    57. Increased Prevalence of Vitamin D Deficiency in Patients with Alopecia Areata: A Systematic Review and Meta-Analysis JEADV. Journal of the European Academy of Dermatology and Venereology/Journal of the European Academy of Dermatology and Venereology · 2018
    58. Cancer Risk in Patients with Alopecia Areata: A Nationwide Population-Based Matched Cohort Study Cancer Medicine · 2018
    59. Vitamin D Deficiency in Patients With Alopecia Areata: A Systematic Review and Meta-Analysis Journal of the American Academy of Dermatology · 2017
    60. Alopecia Areata: Treatment Options and Efficacy Journal of the American Academy of Dermatology · 2017
    61. Evidence-Based Guideline for the Treatment of Androgenetic Alopecia in Women and Men – Short Version Journal of The European Academy of Dermatology and Venereology · 2017
    62. Lichen Planopilaris in a Latin American (Chilean) Population: Demographics, Clinical Profile, and Treatment Experience Clinical and experimental dermatology · 2017
    63. Efficacy and Safety of Topical Calcipotriol in Management of Alopecia Areata: A Pilot Study Dermatologic Therapy · 2017
    64. The Effect of Platelet-Rich Plasma in Hair Regrowth: A Randomized Placebo-Controlled Trial Stem Cells Translational Medicine · 2015
    65. Successful Treatment of Epidermal Growth Factor Receptor Inhibitor-Induced Alopecia with Doxycycline JAAD Case Reports · 2015
    66. Topical Calcipotriol Therapy for Mild-to-Moderate Alopecia Areata: A Retrospective Study PubMed · 2015
    67. Effectiveness of 308-nm Excimer Laser Therapy in Treating Alopecia Areata by Examining Treated Sides of Selected Alopecic Patches Dermatology · 2015
    68. Frontal Fibrosing Alopecia: A Multicenter Review of 355 Patients Journal of The American Academy of Dermatology · 2014
    69. Effect of Pumpkin Seed Oil on Hair Growth in Men with Androgenetic Alopecia: A Randomized, Double-Blind, Placebo-Controlled Trial Evidence-based Complementary and Alternative Medicine · 2014
    70. Experimental Evaluation of Ebastine, a Second-Generation Antihistamine, as a Supportive Medication for Alopecia Areata Journal of Dermatological Science · 2010
    71. Ketoconazole as an Adjunct to Finasteride in the Treatment of Androgenetic Alopecia in Men Medical Hypotheses · 2003
    72. The Effects of Finasteride on Scalp Skin and Serum Androgen Levels in Men with Androgenetic Alopecia Journal of The American Academy of Dermatology · 1999
    73. Ketoconazole Shampoo: Effect of Long-Term Use in Androgenic Alopecia Dermatology · 1998